Genetic interrogation of circulating multiple myeloma cells at single-cell resolution

Area of Science:

• Hematology
• Oncology
• Genetics

Background:

• Multiple myeloma (MM) is an incurable blood cancer characterized by eventual treatment resistance.
• Clonal evolution and genetic heterogeneity drive the development of drug-resistant MM.
• Current monitoring via bone marrow biopsy is invasive and impractical for serial assessment.

Purpose of the Study:

• To evaluate the utility of circulating tumor cells (CTCs) for noninvasively monitoring MM genomic evolution.
• To compare the genetic information obtained from CTCs with traditional bone marrow biopsies.
• To assess the potential of CTCs for classifying MM and identifying prognostic markers.

Main Methods:

• Isolation and single-cell characterization of CTCs from peripheral blood.
• Genomic and RNA sequencing of isolated CTCs.
• Comparison of CTC-derived genetic data with bone marrow MM cell data.

Main Results:

• CTCs accurately recapitulate the genetic landscape of bone marrow MM.
• CTCs provide sensitive detection of mutations, sometimes exceeding bone marrow biopsy sensitivity.
• Single CTC RNA sequencing allows for MM classification and prognostic gene assessment.

Conclusions:

• Noninvasive CTC analysis is a viable alternative to bone marrow biopsy for monitoring MM.
• Genomic characterization of CTCs can track the emergence of drug-resistant subclones.
• Incorporating CTC analysis into clinical trials can improve MM treatment monitoring and therapeutic strategies.